The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
New technologies and capabilities supporting the development of novel Molecular RadioTherapy agents
Read our Oncodesign-Services' poster which provides cutting-edge technologies and products to support the development of radiopharmaceuticals for theranostics.
Next frontier in cancer: deep dive into oncolytic viruses
In this blog, we pay attention in the development of oncolytic viruses (OVs) which destroy cancer cells and leverage the host immune system to enhance the effect.
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
Inactivated vaccines inducing durable cross-protective responses, safety and maintaining preparedness for future seasonally emerging SARS-CoV-2 variants
Meet Pierre !
Discover the mission and daily life of Pierre, Study & Research director in Pharmaco-imaging department.
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules
More than 30 international leading experts has developed proposals to facilitate integration of the microbiome in drug discovery and development.
Oncodesign Services x ZoBio – ITW
Follow our exciting story and stay tuned to witness the positive impact this union can have on research!
Phinc & Oncodesign Services
With Oncodesign Services and Phinc, unlocking the power of PBPK prediction and ADMET experimentation for a better drug development!
Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms
Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!
Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models
This study investigated in vivosynergism between eribulin and palbociclib in a breastcancer patient-derived xenograft (PDX) model.
Oncodesign Services Acquires ZoBio
Acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery, by Oncodesign Services.